175 related articles for article (PubMed ID: 29042238)
1. Novel strategy for immunomodulation: Dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology.
Lin S; Cai B; Quan G; Peng T; Yao G; Zhu C; Wu Q; Ran H; Pan X; Wu C
Eur J Pharm Biopharm; 2018 Jan; 122():104-112. PubMed ID: 29042238
[TBL] [Abstract][Full Text] [Related]
2. Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution.
Wang Q; Yao G; Dong P; Gong Z; Li G; Zhang K; Wu C
Eur J Pharm Sci; 2015 Jan; 66():148-56. PubMed ID: 25446513
[TBL] [Abstract][Full Text] [Related]
3. Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array.
Lin S; Quan G; Hou A; Yang P; Peng T; Gu Y; Qin W; Liu R; Ma X; Pan X; Liu H; Wang L; Wu C
J Control Release; 2019 Jul; 306():69-82. PubMed ID: 31145948
[TBL] [Abstract][Full Text] [Related]
4. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
[TBL] [Abstract][Full Text] [Related]
5. Myristic acid-modified thymopentin for enhanced plasma stability and immune-modulating activity.
Tan Y; Wang W; Wu C; Pan Z; Yao G; Fang L; Su W
Int Immunopharmacol; 2017 Jun; 47():88-94. PubMed ID: 28365509
[TBL] [Abstract][Full Text] [Related]
6. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
[TBL] [Abstract][Full Text] [Related]
9. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
Chen MC; Ling MH; Lai KY; Pramudityo E
Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
[TBL] [Abstract][Full Text] [Related]
10. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
11. [Research on thymopentin-loaded N-trimethyl chitosan nanoparticles administered through mouth].
Tang SW; Yuan XJ; Zhang ZR; Song QG; He Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):885-8. PubMed ID: 17953385
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)/poly(lactide-co-glycolide acid) implants.
Wei G; Jin L; Xu L; Liu Y; Lu W
Int J Pharm; 2010 Oct; 398(1-2):123-9. PubMed ID: 20674730
[TBL] [Abstract][Full Text] [Related]
13. Multivesicular liposomes for the sustained release of thymopentin: stability, pharmacokinetics and pharmacodynamics.
Zuo J; Gong T; Sun X; Huang Y; Peng Q; Zhang Z
Pharmazie; 2012 Jun; 67(6):507-12. PubMed ID: 22822538
[TBL] [Abstract][Full Text] [Related]
14. Vesicular phospholipid gels using low concentrations of phospholipids for the sustained release of thymopentin: pharmacokinetics and pharmacodynamics.
Zhong Y; Chen L; Zhang Y; Li W; Sun X; Gong T; Zhang Z
Pharmazie; 2013 Oct; 68(10):811-5. PubMed ID: 24273885
[TBL] [Abstract][Full Text] [Related]
15. Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.
Zhang T; Qin XY; Cao X; Li WH; Gong T; Zhang ZR
Acta Pharmacol Sin; 2019 Apr; 40(4):514-521. PubMed ID: 30002492
[TBL] [Abstract][Full Text] [Related]
16. Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean phospholipid and PHBHHx polymer.
Wu C; Zhang M; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Elhissi AM; Sun X
Mol Pharm; 2014 Oct; 11(10):3371-7. PubMed ID: 24641274
[TBL] [Abstract][Full Text] [Related]
17. Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin.
Demir YK; Akan Z; Kerimoglu O
PLoS One; 2013; 8(5):e63819. PubMed ID: 23675508
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin.
He W; Jiang X; Zhang ZR
J Pharm Sci; 2008 Jun; 97(6):2250-9. PubMed ID: 17853430
[TBL] [Abstract][Full Text] [Related]
19. A simple method of microneedle array fabrication for transdermal drug delivery.
Kochhar JS; Goh WJ; Chan SY; Kang L
Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
[TBL] [Abstract][Full Text] [Related]
20. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.
Zheng AP; Wang JC; Lu WL; Zhang X; Zhang H; Wang XQ; Zhang Q
J Nanosci Nanotechnol; 2006; 6(9-10):2936-44. PubMed ID: 17048501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
